In a 23-year-old man with severe obesity, adding semaglutide and a lower calorie diet to phentermine, topiramate and metformin was followed by a 32.5% total body weight reduction.
In plain wordsIn one young man with severe obesity, adding semaglutide to other weight-loss drugs and a lower calorie diet was followed by a 32.5% weight loss.
- Peptide
- Semaglutide
- Outcome
- DecreaseTotal body weight reduction
- Study
n = 1
- Outcome group
- Body weight · Metabolic and weight
Measurements
- Total body weight reduction
- 32.5%
- regimen with semaglutide added
Source sentences
Subsequently, semaglutide (a glucagon-like peptide-1 receptor agonist) was added, along with a lower calorie diet, which resulted in a 32.5% total body weight reduction, approximating that which can be achieved following metabolic/bariatric surgery.
1 context sentence(design, population, supporting numbers)
In addition to lifestyle modification therapy, he was started on phentermine, topiramate, and metformin, which only resulted in weight stabilization after 1 year.
In this study, Semaglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Semaglutide.